Drugs / ARQ 171
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00398840 | Nov 2006 → Sep 2008 | cancer | ArQule, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARQ 171 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00398840 ↗ |
| Route | Intravenous | “intravenous infusion (IVI)” NCT00398840 ↗ |